DNA REPAIR AND DISEASE
======================

The maintenance of the integrity of DNA is of a paramount biological importance as it serves as the central repository for all genetic information. A network of biochemical pathways exists in all cells to maintain the informational and structural fidelity of DNA. These pathways are characterized, in part, by the types of modifications to the DNA to which they respond. The dissection of these pathways has involved a coordinated biochemical, genetic, and molecular biological approach where specific enzymatic defects are correlated with mutations at particular chromosomal loci, and distinctive cellular phenotypes. In humans, the specific DNA repair defects have been correlated with particular inherited diseases. Hereditary nonpolyposis colorectal cancer, for example, is a disorder associated with mutations in genes encoding components of the mismatch repair apparatus that lead to profound defects in cellular mismatch repair, and increases in genome instability \[[@B1]\]. Similarly, a trio of phenotypically disparate diseases, XP, CS, and TTD have been connected with mutations in genes that encode subunits of the NER and TFIIH apparatus, that confer measurable defects in NER and transcription \[[@B2], [@B3], [@B4]\]. The broad symptomology of these diseases most likely reflects the multiple biochemical defects caused by the mutations, some of which have not been extensively explored. This work focus on some of the less described effects of mutations in the NER/TFIIH apparatus on genome stability, and their potential implications with respect to human disease.

NUCLEOTIDE EXCISION REPAIR
==========================

NER plays a critical role in the maintenance of genomic integrity because of its broad substrate specifity. It plays an important role in the removal of such diverse lesions as UV light induced photoproducts as well as chemically induced bulky adducts, crosslinks, and oxidized bases. NER has been functionally conserved throughout phylogeny, although the apparatus in prokaryotes and eukaryotes is substantially different. NER in eukaryotes involves the concerted action of up to 30 proteins and has been reconstituted in vitro \[[@B5], [@B6]\]. NER occurs in the context of two distinct pathways related to the way the lesions are identified. General genome repair (GGR) responds to genome-wide damage, which in mammals is recognized by the XPC/HHR23B complex \[[@B7]\]. Transcription coupled repair (TCR) is focused exclusively on the repair of lesions on the transcribed strand of actively transcribed genes \[[@B8]\], and is thought to involve recognition of RNA polymerase II stalled at a lesion by the CSA and CSB proteins \[[@B9], [@B10]\]. The *XPA* protein then orchestrates the assembly of a complex including the single-stranded DNA binding protein RPA and the core of the TFIIH complex at the site of the lesion \[[@B11]\]. This complex unwinds the DNA surrounding the lesion in an ATP-dependent process that involves the helicase activities of the *XPB* and *XPD* proteins, components of the TFIIH core complex \[[@B12], [@B13]\]. Interestingly, only the helicase activity of *XPB* is required for TFIIH-mediated melting of promoter DNA during the initiation of transcription, while *XPD* helicase activity plays a minor role in RNA polymerase II promoter escape \[[@B14]\]. Two structure-specific endonucleases, the ERCC1/XPF heterodimer, that cleaves on the 3′ side of the lesion, and *XPG*, that cleaves on the 5′ side of the lesion, are responsible for the removal of a 24--32 base oligonucleotide containing the lesion \[[@B15], [@B16]\]. The resulting gap is filled by DNA polymerases δ and ɛ, and repair is completed by ligation \[[@B5]\].

NER PHOTOSENSITIVITY SYNDROMES
==============================

XP, CS, and TTD have been ascribed to changes in NER and TFIIH function. Complementation analysis, conducted by analyzing the phenotypes of cells derived from the fusion of cells from different patients, identified several complementation groups for each disease \[[@B11]\]. Seven complementation groups, designated XP-A through XP-G, have been identified for XP. Two complementation groups, CS-A and CS-B, have been identified for CS. Three complementation groups, XP-B, XP-D, and XP-G, have been determined for the combined CS/XP patients. Three complementation groups, XP-B, XP-D, and TTD-A, have been identified for TTD. Most of the genes corresponding to these complementation groups have been cloned and the mutations responsible for disease in individual kindreds have been identified.

XP, CS, and TTD patients have distinct symptoms that likely reflect the participation of the mutant proteins in multiple biochemical processes. In patients, symptoms can often be correlated with specific biochemical defects. An example for each disease is listed below. XP patients exhibit distinct alterations of the texture and pigmentation of the skin that are related to exposure to the sun. They are also enormously predisposed to both sunlight-induced and internal cancers, consistent with defects in NER \[[@B17]\]. For example, an 80% reduction in cellular NER activity in an XP patient homozygous for a particular *XPF* mutation correlates well with the acute reactions to sun exposure and skin cancer that were also observed \[[@B18]\]. CS patients present symptoms of poor growth and developmental deformity that are most likely due to defective transcription. Accordingly, extracts of cells from patients with particular *CSA* and *CSB* mutations have been shown to support reduced levels of RNA polymerase II mediated transcription, as have cells from patients with combined XP/CS disease that are due to a mutation in *XPB* \[[@B19]\]. TTD patients suffer from brittle hair and nails, scaly skin and developmental abnormalities that are probably related to defects in NER and transcription. In support of this, fever inducible hair loss was correlated with temperature sensitive transcription and NER in the cells of patients with specific *XPD* mutations \[[@B20]\].

STUDIES WITH MODEL SYSTEMS
==========================

The extraordinary level of conservation of the NER and TFIIH apparatus among eukaryotes permits the extensive use of model systems to better explore the genetic and biochemical control of theses processes. Studies in rodents, flies, plants, and fungi have all contributed to the understanding of the role played by the NER and TFIIH apparatus in eukaryotes \[[@B21], [@B22], [@B23], [@B24], [@B25], [@B26]\]. However, trangenic mice and budding yeast have been particularly helpful in studying NER and TFIIH at the molecular level, as well as their effects on the phenotype of the organism. For example, in a recent study, isogenic strains of mice homozygous for null alleles of *XPA* or *CSB* were found to be extremely sensitive to a carcinogen that forms bulky adducts on DNA, while an *XPC* null strain was not \[[@B27]\]. This suggests that *XPA*-dependent and CSB-dependent TCR is critical for survival to exposure to an important class of carcinogens, while *XPC*-dependent GGR is not. Such studies are very important in determining how mammals respond to particular types of DNA damage. Mice have also been used to further explore the phenotypic effects of NER mutations known to cause disease in humans. For example, a strain of mouse was created that was homozygous for an *XPD* mutation analogous to the one found in several NER-deficient TTD patients \[[@B28]\]. The mice exhibited hypersensitivity to UV exposure and a cellular NER defect that was very similar to the TTD symptomology but, also exhibited a marked propensity toward UV-induced and carcinogen-induced skin cancer that was not observed in patients. This suggests the possibility that the NER defects observed in TTD patients could lead to cancer, an observation of potential clinical importance.

The study of NER and TFIIH in budding yeast and mammalian cells has been essentially contemporaneous. The observation that NER and transcription are genetically and biochemically linked occurred nearly simultaneously in the two systems, significantly accelerating the description of eukaryotic NER and transcription initiation at the molecular level \[[@B29], [@B30]\]. The degree of similarity between the apparatus in humans and yeast is extraordinary, permitting investigators to examine the impact of disease causing alleles of human NER genes on yeast. In one study, two TTD alleles of *XPD* were unable to complement the lethal effect of a null allele of the *RAD3* gene, the budding yeast homolog of *XPD*, while wild-type and helicase-defective alleles of *XPD* were able to complement \[[@B31]\]. Since the essential function of Rad3/XPD is thought to be its role in transcription initiation, the authors concluded that the TTD alleles confer a transcription defect, and, therefore, that the disease may be due to defective transcription of a critical gene, or genes.

NER, TFIIH, AND THE MAINTENANCE OF GENOME STABILITY IN BUDDING YEAST
====================================================================

The careful study of NER in budding yeast has revealed its impact on cellular processes yet to be recognized in other organisms. These unexpected relationships could provide insight into clinically important roles for the human NER apparatus that have yet to be carefully explored, especially when the disease phenotype is complex as in CS and TTD. An important example is provided by the *RAD1* and *RAD10* genes, homologs of *XPF* and *ERCC1*. Null mutations in *RAD1* and *RAD10* confer profound defects in several different types of homologous recombination \[[@B32], [@B33]\]. Studies analyzing the recombinational repair of defined double-strand breaks (DSBs) revealed that *RAD1* and *RAD10* were required to remove nonhomologous sequences from the ends of recombining molecules, an important step in the creation of certain genome rearrangments \[[@B34]\]. *RAD1* and *RAD10* also play a critical role in recombination between short sequences, which is likely to be vital for the maintenance of genome stability \[[@B35]\]. All of these effects are apt to be related to the role of the Rad1-Rad10 nuclease in the cleavage of important recombination intermediates \[[@B34], [@B35], [@B36]\].

The TFIIH machinery has also been implicated in the maintenance of genome stability. Mutant alleles of *RAD3*, *SSL1*, and *SSL2* (homologs of *XPD*, *P44*, and *XPB*) have been isolated that confer elevated rates of mutation and recombination. Several *rad3* mutants have been isolated that exhibit increased rates of mutation and/or recombination but not defective transcription nor NER, indicating that Rad3 possesses important cellular activities that are independent of transcription and NER \[[@B37], [@B38]\]. Interestingly, a pair of these mutant alleles, *rad3-101* (S74F) and *rad3-102* (H661Y), accumulate DSBs and are synthetically lethal in combination with mutations in recombinational repair genes, strongly suggesting that Rad3 influences either the creation of DSBs, or their processing by homologous recombination \[[@B38]\]. Another allele of *RAD3*, *rad3-G595R*, blocks the degradation of DSBs, which stimulates genome rearrangement by recombination between short repeated sequences \[[@B35], [@B36], [@B37], [@B38], [@B39], [@B40], [@B41]\]. The analogous mutations in *XPD* are of potential medical importance as they would be within regions that encode conserved helicase domains of the protein that are mutated in XP, TTD, and XP/CS patients (Figure [1](#F1){ref-type="fig"}), \[[@B42], [@B43], [@B44]\]. Since specific mutations in *SSL1* and *SSL2* that encode additional members of the heteromeric core of budding yeast TFIIH \[[@B29]\] also stimulate short-sequence recombination (SSR) by blocking the degradation of DSBs \[[@B40], [@B41]\], it appears that TFIIH acts to maintain genome stability by restricting recombination between repetitive DNA sequences. We speculate that SSR could potentially contribute to the symptoms observed in XP, XP-CS, and TTD patients, as SSR in the human genome has been found to lead to a variety of diseases \[[@B45]\].

Recently, it was revealed that by restricting the movement of the retrotransposon Ty1, TFIIH plays an additional, critical role in the maintenance of genome stability in budding yeast. Ty1 can move either by integrase mediated transposition, or by insertion of Ty cDNA into existing Ty or δ elements (the Ty1 long-terminal repeat) by homologous recombination \[[@B47]\]. Components of TFIIH were discovered to play a role in restricting Ty mobility when specific *rad3* and *ssl2* mutants with increased levels of Ty1 movement were isolated \[[@B48]\]. Other *rad3* and *ssl2* mutants that confer extreme UV sensitivity do not stimulate Ty mobility, separating the NER and Ty maintenance functions of these genes. The increases in Ty mobility were correlated with a substantial elevation of the steady-state level of Ty1 cDNA, suggesting either that the *rad3-RTT* (regulator of Ty transposition) and *ssl2-RTT* mutations increase the synthesis of Ty1 cDNA, or decrease its degradation. Importantly, the level of Ty1 RNA and Ty1 proteins remained unchanged in the *rad3* and *ssl2* mutants. Another interesting observation is that other NER genes, such as *RAD2* and *RAD1* do not appear to be involved in Ty transposition \[[@B49]\].

In a subsequent study, the increased level of Ty1 cDNA was found not to be due to increased cDNA synthesis suggesting that TFIIH plays a role in the degradation of Ty1 cDNA \[[@B41]\]. This same study linked TFIIH-control of SSR and Ty1 movement by showing that *rad3-G595R* and *ssl2-RTT* increase both SSR and Ty1 movement while increasing the stability of both Ty1 cDNA and DSBs. It remains unclear whether TFIIH plays a direct or an indirect role in the degradation of the ends of DNA molecules, however, the helicase activities of Rad3 and Ssl2 suggest that TFIIH could play a role in opening the ends of DNA molecules, thereby facilitating their processing by exonucleases.

Blocking the degradation of DSBs and Ty1 cDNAs could enhance Ty1 movement and SSR in multiple ways. It could preserve sequences at the ends of the molecules that are important for SSR and Ty1 movement. For example, a DSB in a short repetitive sequence creates ends that are never far from the border of homology with potential donor repeats, such that any erosion of the ends would significantly decrease their ability to pair and recombine. Similarly, loss of the sequences at the ends of Ty1 cDNA would block transposition by Ty1 integrase. Another way (that increasing the stability of DNA ends might elevate SSR and Ty mobility) could be by prolonging the signal that elicits the DNA damage checkpoint. Pausing the cell cycle for a protracted period may improve the likelihood that the ends of DSBs in short repeats can find homologous sequences, or that the Ty1 preintegration complex can complete a transposition event. Changes in checkpoint activity have been shown to affect the frequencies of other genome rearrangements \[[@B50]\]. These and other mechanisms could be working simultaneously to increase genome rearrangement in *rad3* and *ssl2* mutant budding yeast. By extension, similar defects in the cells of XP, XP-CS, or TTD patients with mutations in the *XPD* or *XPB* genes might contribute to these diseases.

Figures and Tables
==================

![Amino acid changes in the human XPD and budding yeast Rad3 helicases that lead to phenotypic changes. The primary amino acid sequences of human XPD and yeast Rad3 are represented by the black bar. The seven conserved helicase domains are represented by white boxes and are named according to the accepted nomenclature \[[@B42]\]. The positions of these domains in the primary sequence are listed in bold print as described in \[[@B46]\]. Positions of altered residues in the primary sequence of XPD in XP, XP/CS, and TTD patients \[[@B44]\] are marked with a light hash mark above the black bar. The corresponding diseases are marked with an X for XP, a C for XP/CS, and a T for TTD. The amino acid changes are listed in parentheses. Changes in the Rad3 primary sequence \[[@B38], [@B39]\] are represented by hash marks below the black bar. The corresponding phenotypic changes are denoted by a U for UV sensitive, an R for elevated recombination, and/or mutation, and a T for transcription defective. Corresponding amino acid changes are listed in parentheses.](20102.fig.001){#F1}
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